Susunod

Auto-play

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 Mga view • 06/15/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play